Monday 17 September 2012

Asthma

Asthma
  • Chronic inflammatory disease of the airways
  • Three components
    • Reversible airflow limitation
    • Airway hyper-responsiveness to stimuli
    • Inflammation of the bronchi

Epidemiology
  • Prevalence increasing

Aetiology and precipitating factors
  • Atopy and allergy
  • Increased airway responsiveness
  • Cold air, exercise, pollution
  • Occupational, e.g. isocyanates (paint-sprayers)
  • Drugs, e.g. NSAIDs, Beta-blockers

Clinical features
  • Cough
  • Wheeze
  • Breathlessness
  • Chest tightness

Investigations
  • Chest X-ray
  • Lung function tests
  • Peak flow charts
  • Skin testing of allergies

Management
  • Self-management plan
  • Avoid precipitants
  • Stepwise drug treatments
  • B2-agonists (short acting and long acting)
  • Antimuscarinics
  • Anti-inflammatories, e.g. sodium chromoglicate
  • Corticosteroids
  • Leukotriene antagonists

Stepwise treatment
  1. Inhaled short acting B2 agonist as required
  2. Add inhaled steroid 200-800 micrograms/day (400 normal)
  3. Add inhaled Long acting B2 agonists (LABA) and if it doesn't work stop and up dose of inhaled steroid to 800 micrograms/day, it if it works continue it, and if it works but isn't enough continue it but up dose of inhaled steroid to 800 micrograms'/day. If still inadequate try leukotriene receptor antagonists or SR (sustained release) theophylline
  4. Either increase inhaled steroid to 2000 micrograms/day or add a fourth drug such as leukotriene receptor antagonist, SR theophylline, or B2 agonist tablets
  5. Refer to specialist care, keep inhaled steroid dosage at 2000 micrograms/day, use LOWEST effective dose of ORAL steroid

Acute severe asthma
  • Clinical features
    • Inability to complete sentence in one breath
    • RR = 25/min
    • Tachycardia = 110 bpm
    • Peak flow = <50% of predicted normal or best
  • Life-threatening features
    • Silent chest, cyanosis or feeble respiratory effort
    • Exhaustion, confusion, or coma
    • Bradycardia or hypotension
    • Peak flow <30% of predicted normal or best
  • Very severe life-threatening features
    • A high PaCO2 > 6 kPa
    • A very low PaO2 < 8kPa despite oxygen
    • A low and falling arterial pH
  • Management
    • Reassure the patient and monitor pulse oximetry and arterial blood gases
    • Give oxygen 40-60%
    • Nebulised B2 agonist e.g. salbutamol 5mg and repeat if no improvement otherwise use 4 hourly
    • Add nebulised anti-muscarinics e.g. ipratropium bromide 0.5mg
    • Give IV steroids e.g. hydrocortisone 200mg IV every 4 hours
    • Exclude pneumothorax on CXR
    • If no improvement consider IV infusion of magnesium sulphate or salbutamol and ventilation

No comments:

Post a Comment